• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过降低粘性粉末的团聚强度来改善难溶性药物的解团聚和溶解。

Improving the de-agglomeration and dissolution of a poorly water soluble drug by decreasing the agglomerate strength of the cohesive powder.

机构信息

Department of Pharmaceutics, College of Pharmacy, Qassim University, P.O. Box 6151, Buraidah 51442, Saudi Arabia.

出版信息

Int J Pharm. 2013 Nov 30;457(1):101-9. doi: 10.1016/j.ijpharm.2013.09.030. Epub 2013 Sep 27.

DOI:10.1016/j.ijpharm.2013.09.030
PMID:24080334
Abstract

Influence of ternary, poorly water-soluble components on the agglomerate strength of cohesive indomethacin mixtures during dissolution was studied to explore the relationship between agglomerate strength and extent of de-agglomeration and dissolution of indomethacin (Ind). Dissolution profiles of Ind from 20% Ind-lactose binary mixtures, and ternary mixtures containing additional dibasic calcium phosphate (1% or 10%; DCP), calcium sulphate (10%) and talc (10%) were determined. Agglomerate strength distributions were estimated by Monte Carlo simulation of particle size, work of cohesion and packing fraction distributions. The agglomerate strength of Ind decreased from 1.19 MPa for the binary Ind mixture to 0.84 MPa for 1DCP:20Ind mixture and to 0.42 MPa for 1DCP:2Ind mixture. Both extent of de-agglomeration, demonstrated by the concentration of the dispersed indomethacin distribution, and extent of dispersion, demonstrated by the particle size of the dispersed indomethacin, were in descending order of 1DCP:2Ind>1DCP:20Ind>binary Ind. The addition of calcium sulphate dihydrate and talc also reduced the agglomerate strength and improved de-agglomeration and dispersion of indomethacin. While not definitively causal, the improved de-agglomeration and dispersion of a poorly water soluble drug by poorly water soluble components was related to the agglomerate strength of the cohesive matrix during dissolution.

摘要

研究了三元、低水溶性成分对粘性吲哚美辛混合物在溶解过程中团聚强度的影响,以探索团聚强度与吲哚美辛(Ind)解聚和溶解程度之间的关系。测定了吲哚美辛与乳糖(20%Ind)二元混合物和含有额外磷酸氢钙(1%或 10%;DCP)、硫酸钙(10%)和滑石(10%)的三元混合物的溶解曲线。通过对粒径、内聚功和堆积分数分布的蒙特卡罗模拟来估计团聚强度分布。Ind 的团聚强度从二元 Ind 混合物的 1.19 MPa 降低到 1DCP:20Ind 混合物的 0.84 MPa 和 1DCP:2Ind 混合物的 0.42 MPa。解聚程度(由分散的吲哚美辛分布浓度表示)和分散程度(由分散的吲哚美辛粒径表示)都按 1DCP:2Ind>1DCP:20Ind>二元 Ind 的顺序降低。硫酸钙二水合物和滑石的添加也降低了吲哚美辛的团聚强度并改善了其解聚和分散。虽然不能确定因果关系,但低水溶性成分对低水溶性药物的改善解聚和分散与溶解过程中粘性基质的团聚强度有关。

相似文献

1
Improving the de-agglomeration and dissolution of a poorly water soluble drug by decreasing the agglomerate strength of the cohesive powder.通过降低粘性粉末的团聚强度来改善难溶性药物的解团聚和溶解。
Int J Pharm. 2013 Nov 30;457(1):101-9. doi: 10.1016/j.ijpharm.2013.09.030. Epub 2013 Sep 27.
2
Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives.将亲水性差的无机粘性盐添加剂纳入其中可增强吲哚美辛的溶解,与直觉相反。
Eur J Pharm Biopharm. 2011 Nov;79(3):674-82. doi: 10.1016/j.ejpb.2011.06.002. Epub 2011 Jun 14.
3
Understanding agglomeration of indomethacin during the dissolution of micronised indomethacin mixtures through dissolution and de-agglomeration modeling approaches.通过溶解和去团聚建模方法理解微粉化吲哚美辛混合物溶解过程中吲哚美辛的团聚情况。
Eur J Pharm Biopharm. 2005 Feb;59(2):315-23. doi: 10.1016/j.ejpb.2004.07.013.
4
Enhancement of the dissolution of indomethacin in interactive mixtures using added fine lactose.使用添加的细乳糖增强吲哚美辛在交互式混合物中的溶出度。
Eur J Pharm Biopharm. 2007 Nov;67(3):732-42. doi: 10.1016/j.ejpb.2007.04.013. Epub 2007 May 4.
5
Understanding improved dissolution of indomethacin through the use of cohesive poorly water-soluble aluminium hydroxide: effects of concentration and particle size distribution.通过使用具有粘性的难溶性氢氧化铝来理解吲哚美辛溶出度的提高:浓度和粒度分布的影响
J Pharm Sci. 2011 Oct;100(10):4269-80. doi: 10.1002/jps.22605. Epub 2011 May 10.
6
Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.丙酸氟替卡松在干粉吸入剂制剂中的聚集行为。
Eur J Pharm Biopharm. 2012 Apr;80(3):596-603. doi: 10.1016/j.ejpb.2011.12.004. Epub 2011 Dec 14.
7
De-agglomeration of micronized benzodiazepines in dissolution media measured by laser diffraction particle sizing.通过激光衍射粒度分析测定微粉化苯二氮䓬类药物在溶出介质中的解聚情况。
J Pharm Pharmacol. 2003 Jun;55(6):749-55. doi: 10.1211/002235703765951348.
8
Drug agglomeration and dissolution--what is the influence of powder mixing?药物团聚与溶解——粉末混合有何影响?
Eur J Pharm Biopharm. 2009 May;72(1):156-64. doi: 10.1016/j.ejpb.2008.12.015.
9
Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.聚(2-羟乙基甲基丙烯酸酯)水凝胶中吲哚美辛无定形固体分散体的增强动力学溶解度谱。
Eur J Pharm Biopharm. 2012 May;81(1):149-58. doi: 10.1016/j.ejpb.2011.12.016. Epub 2012 Jan 2.
10
Agglomerate formation and growth mechanisms during melt agglomeration in a rotary processor.旋转处理器中熔体团聚过程中的团聚体形成与生长机制。
Int J Pharm. 2005 Nov 4;304(1-2):152-64. doi: 10.1016/j.ijpharm.2005.08.014. Epub 2005 Sep 27.

引用本文的文献

1
Novel Approaches for the Treatment of Pulmonary Tuberculosis.治疗肺结核的新方法。
Pharmaceutics. 2020 Dec 10;12(12):1196. doi: 10.3390/pharmaceutics12121196.